Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
JACC. Heart Failure|November 15, 2020
Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection FractionSean P Murphy, Margaret F Prescott, Alexander Camacho, et al.
JACC. Advances|June 28, 2024
Sex Differences in Coronary Artery Disease Characteristics Among Patients With Type 2 Myocardial InfarctionClaire Lin, Cian P McCarthy, Reza Mohebi, et al.
Journal of the American College of Cardiology|October 1, 2023
Coronary Computed Tomographic Angiography With Fractional Flow Reserve in Patients With Type 2 Myocardial InfarctionCian P McCarthy, Sean P Murphy, Daniel K Amponsah, et al.
JACC. Cardiooncology|April 5, 2021
The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil-Associated Coronary VasospasmAmna Zafar, Zsofia D Drobni, Ramya Mosarla, et al.
European Journal of Cancer (Oxford, England : 1990)|October 18, 2021
Immune checkpoint inhibitors for cancer and venous thromboembolic eventsJingyi Gong, Zsofia D Drobni, Raza M Alvi, et al.
Immunotherapy Advances|September 20, 2021
Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitorsZsofia D Drobni, Sean P Murphy, Raza M Alvi, et al.
Circulation|October 2, 2020
Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic PlaqueZsofia D Drobni, Raza M Alvi, Jana Taron, et al.
JACC. Cardiooncology|January 13, 2023
Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After ImmunotherapyCharlotte Lee, Zsofia D Drobni, Amna Zafar, et al.
Pageof 9